CD8 T cell response in a phase I study of therapeutic vaccination of advanced NSCLC with allogeneic tumor cells secreting endoplasmic reticulum-chaperone gp96-Ig-peptide complexes
Advances in Lung Cancer · 2013
DOI: 10.4236/alc.2013.21002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Lung Cancer, 2013. Verfasst von Luis E. Raez und 7 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Raez, L. E., Walker, G. R., Baldie, P., Fisher, E., Gomez, J. E., Tolba, K., Santos, E. S., & Podack, E. R. (2013). CD8 T cell response in a phase I study of therapeutic vaccination of advanced NSCLC with allogeneic tumor cells secreting endoplasmic reticulum-chaperone gp96-Ig-peptide complexes. Advances in Lung Cancer. https://doi.org/10.4236/alc.2013.21002
Vancouver
Raez LE, Walker GR, Baldie P, Fisher E, Gomez JE, Tolba K, et al. CD8 T cell response in a phase I study of therapeutic vaccination of advanced NSCLC with allogeneic tumor cells secreting endoplasmic reticulum-chaperone gp96-Ig-peptide complexes. Advances in Lung Cancer. 2013. doi:10.4236/alc.2013.21002
BibTeX
@article{Raez2013,
author = {Raez, Luis E. and Walker, Gail R. and Baldie, Paulette and Fisher, Eva and Gomez, Jorge E. and Tolba, Khaled and Santos, Edgardo S. and Podack, Eckhard R.},
title = {CD8 T cell response in a phase I study of therapeutic vaccination of advanced NSCLC with allogeneic tumor cells secreting endoplasmic reticulum-chaperone gp96-Ig-peptide complexes},
journal = {Advances in Lung Cancer},
year = {2013},
doi = {10.4236/alc.2013.21002}
}
EUVIMED